- Motley Fool•11 days ago
The drugmaker's stock hit the skids after a safety signal delayed the clinical progress of a high-value drug candidate.
- Motley Fool•13 days ago
A recent string of positive developments could make this the most exciting biotech stock of the year.
- Zacks•15 days ago
Ionis (IONS) entered into a collaboration agreement with Novartis (NVS) for the development and commercialization of AKCEA-APO(a)-L and AKCEA-APOCIII-L.
ISIS : Summary for Ionis Pharmaceuticals, Inc - Yahoo Finance
Ionis Pharmaceuticals, Inc (ISIS)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
As of 4:00PM EST. Market open.
|Day's Range||0.00 - 0.00|
|52 Week Range|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|